Literature DB >> 6132221

Autoantibodies to vasopressin cells in idiopathic diabetes insipidus: evidence for an autoimmune variant.

W A Scherbaum, G F Bottazzo.   

Abstract

Autoantibodies to vasopressin-secreting cells of human hypothalamus were detected by means of indirect immunofluorescence (IFL) in 13 patients with diabetes insipidus (DI). 11 of 30 patients (36 . 7%) with "idiopathic" and 2 of 32 (6 . 3%) with symptomatic DI were positive, and 139 control patients were negative. The specificity of the reaction vasopressin cells was demonstrated with a 4-layer double-fluorochrome IFL test in which the second sandwich consisted of rabbit antivasopressin or anti-oxytocin counterstained with rhodaminated anti-rabbit immunoglobulin. 5 patients had also antibodies to oxytocin-producing cells. The antibodies reacted with cytoplasmic components distinct from the hormone; they were of IgG, IgA, or IgM class or a combination of these classes, and half of them fixed complement. Maximum titres were 1:32, and the antibodies could not be absorbed out by incubation with vasopressin, oxytocin, neurophysin I, or neurophysin II. Some sera stained as yet unidentified small cells in the hypothalamus. This report suggests that autoimmunity extends to the hypothalamus. Vasopressin-cell antibodies may prove to be useful markers for the diagnosis of an autoimmune variant of diabetes insipidus.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6132221     DOI: 10.1016/s0140-6736(83)91328-4

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  21 in total

1.  A case of lymphocytic infundibuloneurohypophysitis: histophathological studies.

Authors:  K Waki; S Yamada; Y Ozawa; K Seki; Y Endo
Journal:  Pituitary       Date:  1999-05       Impact factor: 4.107

Review 2.  Polyglandular autoimmune syndrome: current concepts.

Authors:  J Meyerson; E E Lechuga-Gomez; P E Bigazzi; P G Walfish
Journal:  CMAJ       Date:  1988-04-01       Impact factor: 8.262

3.  Idiopathic cranial diabetes insipidus associated with idiopathic hypoparathyroidism.

Authors:  A Jabbar; J Akhter
Journal:  Postgrad Med J       Date:  1994-07       Impact factor: 2.401

4.  Autoimmune endocrine diseases.

Authors:  M H De Baets
Journal:  Surv Immunol Res       Date:  1984

5.  Intermediate lobe immunoreactivity in a patient with suspected lymphocytic hypophysitis.

Authors:  Casey Jo Anne Smith; Sophie Bensing; Vicki E Maltby; Mingdong Zhang; Rodney J Scott; Roger Smith; Olle Kämpe; Tomas Hökfelt; Patricia A Crock
Journal:  Pituitary       Date:  2014-02       Impact factor: 4.107

6.  Rabphilin-3A as a Targeted Autoantigen in Lymphocytic Infundibulo-neurohypophysitis.

Authors:  Shintaro Iwama; Yoshihisa Sugimura; Atsushi Kiyota; Takuya Kato; Atsushi Enomoto; Haruyuki Suzuki; Naoko Iwata; Seiji Takeuchi; Kohtaro Nakashima; Hiroshi Takagi; Hisakazu Izumida; Hiroshi Ochiai; Haruki Fujisawa; Hidetaka Suga; Hiroshi Arima; Yoshie Shimoyama; Masahide Takahashi; Hiroshi Nishioka; San-e Ishikawa; Akira Shimatsu; Patrizio Caturegli; Yutaka Oiso
Journal:  J Clin Endocrinol Metab       Date:  2015-04-28       Impact factor: 5.958

7.  A single base substitution in the coding region for neurophysin II associated with familial central diabetes insipidus.

Authors:  M Ito; Y Mori; Y Oiso; H Saito
Journal:  J Clin Invest       Date:  1991-02       Impact factor: 14.808

8.  Cranial diabetes insipidus secondary to arrested hydrocephalus.

Authors:  D G Menzies; J F Shaw; D M Kean; I W Campbell
Journal:  Postgrad Med J       Date:  1988-04       Impact factor: 2.401

Review 9.  Lymphocytic infundibulo-neurohypophysitis: a clinical overview.

Authors:  Philip C Johnston; Luen S Chew; Amir H Hamrahian; Laurence Kennedy
Journal:  Endocrine       Date:  2015-07-29       Impact factor: 3.633

Review 10.  Cryptocrine signaling in the thymus network and T cell education to neuroendocrine self-antigens.

Authors:  V Geenen; B Goxe; H Martens; E Vandersmissen; Y Vanneste; I Achour; O Kecha; P J Lefebvre
Journal:  J Mol Med (Berl)       Date:  1995-09       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.